Skip to main content

Table 1 Patient and primary tumor characteristics (n = 10)

From: Permanent interstitial 125I seed implantation as a salvage therapy for pediatric recurrent or metastatic soft tissue sarcoma after multidisciplinary treatment

 

No. of patients

Percentage (%)

Age at implant (years)

  

 Median (range)

15 (4–20)

 

Gender

  

 Male

7

70

 Female

3

30

Pathology of primary tumor

  

 Fibrosarcoma

5

50

 Alveolar soft tissue sarcoma

2

20

 Primitive neuroectodermal tumor

1

10

 Epithelioid sarcoma

1

10

 Rhabdomyosarcoma

1

10

Primary tumor stage (AJCC 7th de, 2010)

  

 I A

3

30

 II A

1

10

 III

3

30

 IV

3

30

Pre-seed implant therapy

  

 Surgery + EBRT + CTx

1

10

 Surgery + EBRT

3

30

 Surgery + CTx

1

10

 EBRT + CTx

2

20

 Surgery

3

30

Follow-up (month)

  

 Median (range)

27.5 (6–107)

 
  1. Abbreviations: AJCC American Joint Committee on Cancer, EBRT external beam radiotherapy, CTx chemotherapy